MCP-1 Levels in Growth-Restricted Babies
Author Information
Author(s): Briana Despina D., Boutsikou Maria, Baka Stavroula, Papadopoulos George, Gourgiotis Dimitrios, Puchner Karl Philipp, Hassiakos Dimitrios, Malamitsi-Puchner Ariadne
Primary Institution: Athens University Medical School
Hypothesis
Circulating concentrations of MCP-1 might differ between IUGR cases and appropriate for gestational age (AGA) controls.
Conclusion
Reduced maternal and fetal MCP-1 concentrations in IUGR may reflect failure of trophoblast invasion, while increased MCP-1 concentrations in IUGR neonates may indicate enhanced angiogenesis.
Supporting Evidence
- MCP-1 concentrations were significantly lower in IUGR compared to AGA.
- N1 MCP-1 concentrations were significantly elevated in the IUGR group.
- Maternal and fetal MCP-1 concentrations were lower in IUGR cases.
- Fetal MCP-1 concentrations were significantly lower compared to N1 and N4 in both groups.
Takeaway
This study looked at a protein called MCP-1 in mothers and their babies. They found that babies who didn't grow properly had lower levels of this protein, which might mean their bodies weren't working as well.
Methodology
The study measured plasma MCP-1 concentrations in mothers and their infants at specific postnatal days, comparing IUGR and AGA groups.
Potential Biases
Potential bias due to the small sample size and specific population studied.
Limitations
The study did not account for all potential confounding factors affecting MCP-1 levels.
Participant Demographics
40 mothers with 20 IUGR and 20 AGA infants, with various maternal health issues noted.
Statistical Information
P-Value
P < .001 for maternal MCP-1 concentrations in IUGR vs AGA.
Confidence Interval
95% CI: 114.511–219.525 for maternal MCP-1 concentrations.
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website